Wu Yun, Ji Yaoting, Mu Rui, Pan Jiawen, Fan Ruixin, Zhao Yan, Liang Shanshan
State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology, Wuhan University, Wuhan, 430079, Hubei, China.
Center for Endodontics and Periodontics, Optics Valley Branch, School & Hospital of Stomatology, Wuhan University, Wuhan, China.
Inflammation. 2025 May 27. doi: 10.1007/s10753-025-02314-4.
Periodontitis is a chronic inflammatory disease characterized by the progressive destruction of tooth-supporting tissues. Despite extensive research, the molecular mechanisms underlying its pathogenesis remain incompletely understood. This study aimed to investigate the role and regulatory mechanisms of miR-221/222-3p in experimental periodontitis. The expression of miR-221/222-3p in lipopolysaccharide (LPS)-stimulated periodontal ligament cells (PDLCs) and ligation-induced rat periodontitis were detected by RT-qPCR. miR-221/222-3p agomir were administrated topically in ligation-induced rat periodontitis. The therapeutic function of both miRNAs were assessed by micro-CT, TRAP staining, and immunohistochemistry. The mechanisms of miR-221/222-3p function in periodontitis were determined by cell assays. miR-221-3p and miR-222-3p expression were both downregulated in LPS-stimulated PDLCs and ligation-induced periodontitis rat. In vitro, miR-221-3p and miR-222-3p could alleviate the inflammatory damage of PDLCs upon LPS stimulation. Mechanically, PAK1 is demonstrated as a target gene of miR-221/222-3p. Additionally, STAT1 signaling pathway is activated by LPS treatment and STAT1 could bind to the upstream region of the miR-221/222-3p promoter and repress their expression. In vivo, miR-221/222-3p agomir rescued the alveolar bone loss, alleviated the infiltration of osteoclasts and the expression of inflammatory cytokines of periodontitis rats. Our results revealed a novel STAT1-miR-221/222-3p-PAK1 axis in the initiation and progression of periodontitis. Specific targeting this signaling pathway may provide a new therapeutic avenue for periodontitis.
牙周炎是一种慢性炎症性疾病,其特征是牙齿支持组织进行性破坏。尽管进行了广泛研究,但其发病机制背后的分子机制仍未完全了解。本研究旨在探讨miR-221/222-3p在实验性牙周炎中的作用及调控机制。通过RT-qPCR检测miR-221/222-3p在脂多糖(LPS)刺激的牙周膜细胞(PDLCs)和结扎诱导的大鼠牙周炎中的表达。将miR-221/222-3p激动剂局部应用于结扎诱导的大鼠牙周炎。通过显微CT、抗酒石酸酸性磷酸酶(TRAP)染色和免疫组织化学评估这两种微小RNA的治疗功能。通过细胞实验确定miR-221/222-3p在牙周炎中发挥作用的机制。在LPS刺激的PDLCs和结扎诱导的牙周炎大鼠中,miR-221-3p和miR-222-3p的表达均下调。在体外,miR-221-3p和miR-222-3p可减轻LPS刺激后PDLCs的炎症损伤。机制上,已证明PAK1是miR-221/222-3p的靶基因。此外,LPS处理可激活信号转导和转录激活因子1(STAT1)信号通路,且STAT1可与miR-221/222-3p启动子的上游区域结合并抑制其表达。在体内,miR-221/222-3p激动剂挽救了牙槽骨丢失,减轻了破骨细胞浸润和牙周炎大鼠炎症细胞因子的表达。我们的结果揭示了牙周炎发生和发展过程中的一条新的STAT1-miR-221/222-3p-PAK1轴。特异性靶向该信号通路可能为牙周炎提供一种新的治疗途径。